SparingVision

Last updated: August 29, 2025
CEO Stéphane Boissel
CEO Stéphane Boissel
Country: France | Funding: $127.6M (+) | Add Funding

Website: https://sparingvision.com

SparingVision is a biotechnology company focused on the discovering and development of an innovative, therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa.